… Acute bronchitis is a clinical diagnosis characterized by cough due to acute inflammation
of the trachea and large airways without evidence of pneumonia. Pneumonia should be …

… Inhaled corticosteroids plus long-acting beta2 agonists provide clinical benefits. … In
addition, severe acute exacerbations of COPD have an independent negative impact on patient …

… the acute unwanted effects of various beta2 agonist medications are discussed. When beta2
agonists … In this review, acute unwanted effects of beta2 agonists will be considered under …

… with cough or dyspnea after 10 days of acute bronchitis.³ Patients were excluded if they had
been … Beta2-agonists for acute cough or a clinical diagnosis of acute bronchitis. Cochrane …

Purpose: Short acting b2 agonists are recommended to be used≤ 2 canisters per year. It is
suggested that overuse of b2 agonists will lead to increased morbidity and mortality. This …

… Are beta2 agonists effective for improving symptoms of acute cough or a clinical diagnosis
of acute bronchitis … There is insufficient evidence to determine whether beta2 agonists can …

… Inhaled Beta2-Agonists (Bronchodilators) see … BRONCHITIS (AECB) Comment: Antibiotics
are seldom needed for treatment of acute bronchitis because the etiology is usually viral…

Background Three classes of inhaler medication are used to manage chronic obstructive
pulmonary disease (COPD): long‐acting beta₂‐agonists (LABA); long‐acting muscarinic …

… As addressed by GINA, based on studies across asthma severities where as-needed fast-acting
bronchodilators with concomitant ICS decrease severe exacerbations compared with …

… Inhaled long‐acting beta2‐agonists (LABA) and long‐acting muscarinic antagonists (LAMA)
are … Beta2‐agonists stimulate adenylyl cyclase activity and directly cause smooth muscle …